Related Experiment Video
Updated: Aug 10, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer
1Independent Scientist, Los Angeles, CA, USA. jkulsh@gmail.com.
Abstract:
The presence of mutated genes strongly correlates with the incidence of cancer. Decades of research, however, has not yielded any specific causative gene or set of genes for the vast majority of cancers. The Cancer Genome Atlas program was supposed to provide clarity, but it only gave much more data without any accompanying insight into how the disease begins and progresses. It may be time to notice that epidemiological studies consistently show that the environment, not genes, has the principal role in causing cancer. Since carcinogenic chemicals in our food, drink, air, and water are the primary culprits, we need to look at the biochemistry of cancer, with a focus on enzymes that invariably facilitate transformations in a cell. In particular, attention should be paid to the rate-limiting enzyme in DNA synthesis, ribonucleotide reductase (RnR), whose activity is tightly linked to tumor growth. Besides circumstantial evidence that cancer is induced at this enzyme's vulnerable free-radical-containing active site by various carcinogens, its role in initiating retinoblastoma and human papillomavirus (HPV)-related cervical cancers has been well documented in recent years. Blocking the activity of malignant RnR is a certain way to arrest cancer.
Insights
Environmental factors, not just genes, are key to cancer development. Targeting the enzyme ribonucleotide reductase (RnR) offers a promising strategy for arresting tumor growth and treating cancer.
Area of Science:
- Biochemistry
- Oncology
- Environmental Health
Background:
- Decades of research have failed to identify specific causative genes for most cancers.
- The Cancer Genome Atlas provided extensive data but limited insight into cancer's origins and progression.
- Epidemiological studies increasingly highlight the environment's principal role in cancer etiology.
Purpose of the Study:
- To investigate the role of environmental carcinogens in cancer development.
- To explore the biochemical mechanisms underlying cancer initiation and progression.
- To identify key enzymes involved in cancer, focusing on ribonucleotide reductase (RnR).
Main Methods:
- Review of epidemiological and biochemical studies on cancer causation.
- Analysis of the role of environmental factors, particularly carcinogenic chemicals.
- Focus on the enzyme ribonucleotide reductase (RnR) and its function in DNA synthesis.
Main Results:
- Environmental exposures, including chemicals in food, air, and water, are primary cancer culprits.
- Ribonucleotide reductase (RnR), the rate-limiting enzyme in DNA synthesis, is closely linked to tumor growth.
- RnR's active site is implicated in carcinogen-induced DNA damage, with documented roles in retinoblastoma and HPV-related cervical cancers.
Conclusions:
- Environmental factors play a more significant role in cancer than previously emphasized.
- Targeting the enzyme ribonucleotide reductase (RnR) presents a viable therapeutic strategy for cancer treatment.
- Inhibiting malignant RnR activity can effectively arrest cancer progression.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

